Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITEC: High-Dose Vitamin E in COVID-19
NCT07412574Phase 1Completed
- Sponsor
- Universidad Veracruzana
- Start
- Sep 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Placebo (Water) with alpha-tocopherol (2 arms). Primary endpoint: C-Reactive Protein at 3 months. Started Sep 2020; status: completed.
02
Drugs
alpha-tocopherol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT07412574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07412574.